The main strategies in CD treatment are the introduction of corticosteroids, immunosuppression (thiopurines and methotrexate), or combination therapy with biologicals (antitumor necrosis factor [TNF] and antiadhesion molecules) in high‐risk patients in addition to frequent inflammation control.9, 10, 11, 12. This evidence concerns the gene TNF and Cowden disease.